Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Regression of peripapillary choroidal neovascularization after oscillatory transpupillary thermotherapy and anti-VEGF pharmacotherapy.

Peyman G, Tsipursky M, Gohel P, Conway M.

Eur J Ophthalmol. 2011 Mar-Apr;21(2):162-72.

PMID:
20623469
2.

Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.

el Matri L, Chebil A, Kort F, Bouraoui R, Baklouti K, Mghaieth F.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):779-84. doi: 10.1007/s00417-010-1302-4. Epub 2010 Feb 19.

PMID:
20169357
3.

Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.

Rush RB, Rush SW, Aragon AV 2nd, Ysasaga JE.

Am J Ophthalmol. 2014 Aug;158(2):337-44. doi: 10.1016/j.ajo.2014.05.007. Epub 2014 May 17.

PMID:
24844972
5.

Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study.

Giansanti F, Virgili G, Bini A, Rapizzi E, Giacomelli G, Donati MC, Verdina T, Menchini U.

Eur J Ophthalmol. 2007 Mar-Apr;17(2):230-7.

PMID:
17415697
6.

Treatment of peripapillary choroidal neovascularization with intravitreal bevacizumab.

Hoeh AE, Schaal KB, Ach T, Dithmar S.

Eur J Ophthalmol. 2009 Jan-Feb;19(1):163-5.

PMID:
19123169
7.

Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up.

Costagliola C, Semeraro F, Cipollone U, Rinaldi M, della Corte M, Romano MR.

Graefes Arch Clin Exp Ophthalmol. 2009 Aug;247(8):1031-7. doi: 10.1007/s00417-009-1081-y. Epub 2009 Apr 29.

PMID:
19404665
8.

Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration.

Bakri SJ, Couch SM, McCannel CA, Edwards AO.

Retina. 2009 May;29(5):573-8. doi: 10.1097/IAE.0b013e3181a46a8a.

PMID:
19430278
9.

Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.

Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.

Acta Ophthalmol. 2009 Jun;87(4):404-7. doi: 10.1111/j.1755-3768.2008.01262.x. Epub 2008 Sep 8.

10.

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.

PMID:
17333238
11.

Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.

Hatta Y, Ishikawa K, Nishihara H, Ozawa S, Ito Y, Terasaki H.

Retina. 2010 Mar;30(3):495-502. doi: 10.1097/IAE.0b013e3181bcedbe.

PMID:
19996828
12.

Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.

Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F.

Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1283-92. doi: 10.1007/s00417-012-1955-2. Epub 2012 Feb 21.

PMID:
22350060
13.

Treatment of choroidal neovascularization using intravitreal bevacizumab.

Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.

14.

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.

PMID:
17420694
15.

Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.

Yoon JU, Kim YM, Lee SJ, Byun YJ, Koh HJ.

Retina. 2012 May;32(5):949-55. doi: 10.1097/IAE.0b013e318227a9ef.

PMID:
22534553
16.

Choroidal neovascularization of optic disk melanocytoma treated with bevacizumab.

Kamisasanuk T, Uchino E, Sakamoto T.

Eur J Ophthalmol. 2012 May-Jun;22(3):503-5. doi: 10.5301/ejo.5000060.

PMID:
21959681
17.

Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors.

Veritti D, Sarao V, Lanzetta P.

J Ocul Pharmacol Ther. 2013 May;29(4):437-41. doi: 10.1089/jop.2012.0173. Epub 2012 Dec 6.

PMID:
23215753
19.

Changes of choroidal neovascularization in indocyanine green angiography after intravitreal ranibizumab injection.

Lee JE, Kim HW, Lee SJ, Lee JE.

Retina. 2015 May;35(5):999-1006. doi: 10.1097/IAE.0000000000000432.

PMID:
25590857

Supplemental Content

Support Center